Mission Statement
Cytopathology Foundation is a non-profit organization dedicated to the health care for the advancement of art and science of Cytopathology dedicated to the study of cells for proper disease management.

Activities
1. Support the mission statement in general.
2. Support the editorial and publication expenses of CytoJournal.
3. Future activities may include publication and marketing of cytopathology related literature to generate funds.
4. Support any other scholarly activities in Cytopathology and related areas.

About us
Cytopathology Foundation was founded primarily to support the editorial and publication activity of the peer-reviewed, open access scientific cytopathology journal- ‘CytoJournal’.

Vinod B. Shidham, MD, FRCPath, FIAC
President, Cytopathology Foundation Inc
Co-editor-in-chief & Executive editor, CytoJournal (www.cytojournal.com)
Vice-chair- AP, Professor, Director of Cytopathology, Cytopathology fellowship,
& GI pathology,
Dept of Pathology
Karmanos Cancer Center, Detroit Medical Center, & Wayne State University School of Medicine
Old Hutzel Hospital, Div of Cytology,
4707 St. Antoine Blvd, Detroit, MI 48201, USA
vshidham@med.wayne.edu
Direct- (313) 993 0699

CF Board of Directors include:

Kathy Rost
Carleton, MI, USA

Dilip Paradkar
Northville, MI, USA

Anjani Shidham
Grosse Ile, MI, USA

Sonia Shields Stowe
Elm Grove, WI, USA

What is Cytopathology?
Cytopathology is a well established diagnostic sub-specialty of pathology. Instead of using surgically removed tissue to arrive at a diagnosis, it attempts to identify diagnostic and prognostic information from dispersed cells obtained by non-invasive or minimally invasive techniques minimizing the cost and interventional trauma. An example and its greatest success story thus far, is the role it has played in the battle with cervical cancer. The introduction of the Pap smear has contributed immensely to the early diagnosis and significantly decreased mortality of cervical cancer.

Since the initial introduction of Pap smear by George Papanicolaou, cytopathology has undergone significant progress. It is a highly dynamic area of pathology. Aspiration techniques have been enhanced by advances in endoscopy and imaging. Fine needle aspiration biopsy (FNAB) allows not only the retrieval of diagnostic material but also immediate onsite evaluation. This facilitates application of various ancillary techniques (e.g. flowcytometry, cytogenetics, molecular pathology etc). Similar techniques can be applied to the body fluids, washings, brushings, and intraoperative cytology.

Sponsor us (Donate Link)
Cytopathology Foundation Inc is a Non-Profit 501(c)(3) (EIN # 11-3684176) entity in USA. It is primarily dependent on the sponsorship / membership support for its activities and sustenance. As its first endeavor, it is dedicated to support the expenses related to the editorial and publication activities of ‘CytoJournal’- the seminal peer-reviewed scientific journal in the field of Cytopathology. It is published by Scientific Scholar, USA. The publication model is based on the “open access” charter for translating all the benefits of scientific research to the academic community and general public alike without losing precious copyrights by the authors (who accept to share the copyright with general public for a wider impact around the globe). This unique concept however, is heavily dependent on strong financial support to overcome some of the fiduciary issues for healthy start and perennial sustenance.
Cytopathology Foundation seeks financial support from any person, organization, and corporation. Depending on the level of support, the sponsoring entity will be publicly acknowledged by displaying a link on the CytoJournal web page should the level of support approach the significant stable status. This would offer worldwide publicity of sponsorship support along with the link to the home page of the sponsoring entity as applicable. All other supporting entities will also be acknowledged (depending on the donor’s choice) in the list linked through the web-page of CytoJournal.

List of sponsors:
Shidham Foundation (2004, Elm Grove, WI, USA)
Pathikonda and family (2007, Victoria, TX, USA)
Late Geeta Paradkar Memorial Fund (2019, Northville, MI, USA).

Publications
CytoJournal www.cytojournal.com
Why the ‘CytoJournal’ is needed:
The conventional model for journals has performed an admirable job of disseminating research and advancing science. Unfortunately, it cannot fully utilize recent technology nor extend its benefits to either the scientific community or to the general public. With the advent of newer technologies, the Internet and image digitization, the time has come for the development and implementation of a new model beneficial both to the scientific community and general public alike.

The adoption of an open access http://www.cytojournal.com/text.asp?2006/3/1/5/41245 model by the Public Library of Science (PLOS) https://www.plos.org/open-access and other scientific organizations including the National Institute of Health (NIH) http://grants1.nih.gov/grants/guide/notice-files/NOT-OD-03-032.html has provided an impetus for the creation of a new type of journal. A journal model which yields a free, open access, peer-reviewed, research publication platform with global reach and wider public dissemination.

Additional benefits of an Internet-based journal would include rapid turnaround time, real time publication, significant cost savings, and a reduction in the environmental burden associated with the production and disposal of a print publication https://www.youtube.com/watch?v=L5rVH1KGBCY. Presumably in the future, the majority of research publications will be of this type. At present, none of the existing journals in the field of cytopathology belong to this category.

Free flow of scientific information is crucial for the advancement of disease diagnosis and management. ‘CytoJournal’ is an open access cytopathology journal with online outreach. It rigorously follows the quality control through traditional peer-review processes. It should positively influence the advancement of the scientific community in general and diagnostic cytopathology in particular around the world.

Contact us-

Vinod Shidham, MD, FRCPath, FIAC
vshidham@med.wayne.edu
Direct- (313) 993 0699

For feedback please write to-
cytojournal@cytojournal.com